We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-0.65%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$10.7B
AUM Growth
-$506M
Cap. Flow
-$174M
Cap. Flow %
-1.63%
Top 10 Hldgs %
9.5%
Holding
932
New
60
Increased
296
Reduced
331
Closed
64

Top Buys

Rank Stock Value
1
MRX
Marex Group Limited Ordinary Shares
MRX
+$25.9M
2
ENOV icon
Enovis
ENOV
+$23.7M
3
BANC icon
Banc of California
BANC
+$21.4M
4
ASO icon
Academy Sports + Outdoors
ASO
+$21.3M
5
ATKR icon
Atkore
ATKR
+$19M

Top Sells

Rank Stock Value
1
FORM icon
FormFactor
FORM
+$30.5M
2
IBTX
Independent Bank Group, Inc.
IBTX
+$25.4M
3
LECO icon
Lincoln Electric
LECO
+$21.7M
4
FTAI icon
FTAI Aviation
FTAI
+$21.1M
5
ARES icon
Ares Management
ARES
+$20.5M

Sector Composition

Rank Sector Weight
1 Industrials 27.1%
2 Technology 20.67%
3 Financials 13.36%
4 Consumer Discretionary 11.61%
5 Healthcare 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FBNC icon
801
First Bancorp
FBNC
$2.61B
$447K ﹤0.01%
14,000
-5,000
-26% -$159K
VYX icon
802
NCR Voyix
VYX
$1.19B
$428K ﹤0.01%
+34,618
New +$436K
APPS icon
803
Digital Turbine
APPS
$982M
$401K ﹤0.01%
241,500
– –
KLG
804
DELISTED
WK Kellogg Co
KLG
$395K ﹤0.01%
+24,014
New +$487K
WDFC icon
805
WD-40
WDFC
$2.98B
$395K ﹤0.01%
1,799
– –
TVTX icon
806
Travere Therapeutics
TVTX
$5.17B
$391K ﹤0.01%
47,573
– –
ACH
807
Accendra Health
ACH
$254M
$391K ﹤0.01%
+28,959
New +$593K
KIDS icon
808
OrthoPediatrics
KIDS
$513M
$380K ﹤0.01%
13,220
-42,403
-76% -$1.3M
ENV
809
DELISTED
ENVESTNET, INC.
ENV
$376K ﹤0.01%
6,000
– –
ATNM icon
810
Actinium Pharmaceuticals
ATNM
$26.3M
$370K ﹤0.01%
50,000
– –
OPBK icon
811
OP Bancorp
OPBK
$235M
$366K ﹤0.01%
38,163
+23,663
+163% +$226K
FOSL icon
812
Fossil Group
FOSL
$260M
$364K ﹤0.01%
252,754
-1,397,780
-85% -$1.59M
AMPH icon
813
Amphastar Pharmaceuticals
AMPH
$907M
$363K ﹤0.01%
+9,076
New +$376K
WABC icon
814
Westamerica Bancorp
WABC
$1.39B
$348K ﹤0.01%
+7,176
New +$343K
CRVL icon
815
CorVel
CRVL
$3.18B
$347K ﹤0.01%
+4,089
New +$338K
SCSC icon
816
Scansource
SCSC
$1.17B
$342K ﹤0.01%
+7,729
New +$346K
MGEE icon
817
MGE Energy Inc
MGEE
$3.03B
$341K ﹤0.01%
+4,569
New +$357K
CSTL icon
818
Castle Biosciences
CSTL
$742M
$334K ﹤0.01%
15,365
+4,240
+38% +$94.5K
SMG icon
819
ScottsMiracle-Gro
SMG
$4.09B
$325K ﹤0.01%
5,000
– –
RLAY icon
820
Relay Therapeutics
RLAY
$4B
$315K ﹤0.01%
48,381
+34,159
+240% +$233K
VGR
821
DELISTED
Vector Group Ltd.
VGR
$314K ﹤0.01%
29,748
-37,203
-56% -$394K
GES
822
DELISTED
Guess Inc
GES
$314K ﹤0.01%
+15,373
New +$389K
PRME icon
823
Prime Medicine
PRME
$547M
$314K ﹤0.01%
60,999
+14,785
+32% +$89.6K
RHI icon
824
Robert Half
RHI
$4.11B
$309K ﹤0.01%
4,822
– –
WULF icon
825
TeraWulf
WULF
$7.48B
$308K ﹤0.01%
+69,116
New +$186K
31 32
33
34 35

Similar funds

GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $9.98B AUM 4.97% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Royce & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Royce & Associates held 932 positions worth $10.7B, down 4.5% from $11.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Royce & Associates's Q2 2024 filing shows 60 new, 296 increased, 331 reduced and 64 closed positions. Its largest new stake was Marex Group Limited Ordinary Shares: 1,319,744 shares worth $26.4M. The largest sale was FormFactor, an estimated $30.5M.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q2 2024 buy was Marex Group Limited Ordinary Shares: 1,319,744 shares worth $26.4M.
  • Royce & Associates added most to Enovis in Q2 2024, an estimated $23.7M increase.
  • Royce & Associates's biggest Q2 2024 reduction was FormFactor, cutting an estimated $30.5M.
  • Royce & Associates fully exited Valley National Bancorp in Q2 2024, selling an estimated $18M.
  • Royce & Associates's ten largest holdings make up 9.5% of its $10.7B portfolio in Q2 2024.
  • Royce & Associates opened 60 new positions and closed 64 in Q2 2024.
  • Royce & Associates's portfolio value fell 4.5% quarter-over-quarter to $10.7B.

Based on Royce & Associates's 13F filing for Q2 2024, filed 13 Aug 2024.